Seeking Alpha

Shares of The Medicines Company (MDCO +1.7%) move up after being initiated with an Outperform at...

Shares of The Medicines Company (MDCO +1.7%) move up after being initiated with an Outperform at Oppenheimer. The firm says that the Street has all but ignored MDCO's strong pipeline, noting that Angiomax, its key asset, is worth around $19 per share as a stand alone product. Additionally, Phase III data from its antiplatelet-agent Cangrelor is due by early 2013 at the latest, and results from two Phase III studies of its antibiotic treatment Oritavancin should come some time in the first half of next year as well.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|